Form 4: NeuroOne Medical Technologies Executive Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 90 shares of common stock on October 31, 2024, to cover tax obligations.
Summary
- On October 31, 2024, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, disposed of 90 shares of common stock.
- The transaction was executed at a price of $0.97 per share.
- This disposal was related to covering tax obligations.
- Following the transaction, Christianson directly owns 294,079 shares of NeuroOne Medical Technologies Corp.
- The transaction was reported on November 1, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations.
Stakeholder Impact
- The disposal of shares by an insider could be perceived negatively by some shareholders, although it is a small transaction and is related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 10/31/2024 | Date of transaction: Mark Christianson disposed of 90 shares of common stock. |
| 11/01/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.